ANKRD52 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.771610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.045800E-01
Normal-vs-Stage2
1.106170E-01
Normal-vs-Stage3
6.578900E-03
Normal-vs-Stage4
1.370250E-01
Stage1-vs-Stage2
1.756850E-01
Stage1-vs-Stage3
4.252400E-02
Stage1-vs-Stage4
2.090000E-01
Stage2-vs-Stage3
4.895600E-02
Stage2-vs-Stage4
7.219200E-01
Stage3-vs-Stage4
1.614220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.026400E-01
Normal-vs-AfricanAmerican
2.829200E-01
Normal-vs-Asian
5.911800E-02
Caucasian-vs-AfricanAmerican
8.107200E-01
Caucasian-vs-Asian
2.557600E-01
AfricanAmerican-vs-Asian
3.076000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.141400E-01
Normal-vs-Female
1.500600E-01
Male-vs-Female
7.278600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.734400E-01
Normal-vs-Age(41-60Yrs)
3.717000E-01
Normal-vs-Age(61-80Yrs)
1.225350E-01
Normal-vs-Age(81-100Yrs)
6.092200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.767200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.112400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.565780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.517500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.377660E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.850000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.820000E-02
Normal-vs-Daily Drinker
1.122200E-01
Normal-vs-Weekly Drinker
1.078390E-01
Normal-vs-Occasional Drinker
3.788000E-01
Normal-vs-Social Drinker
4.627600E-01
Non Drinker-vs-Daily Drinker
7.099400E-01
Non Drinker-vs-Weekly Drinker
3.404000E-01
Non Drinker-vs-Occasional Drinker
3.513700E-02
Non Drinker-vs-Social Drinker
1.663820E-02
Daily Drinker-vs-Weekly Drinker
6.310000E-01
Daily Drinker-vs-Occasional Drinker
1.454840E-01
Daily Drinker-vs-Social Drinker
8.954100E-02
Weekly Drinker-vs-Occasional Drinker
3.354200E-01
Weekly Drinker-vs-Social Drinker
2.069800E-01
Occasional Drinker-vs-Social Drinker
7.595600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.425760E-01
Normal-vs-Grade 2
9.863900E-02
Normal-vs-Grade 3
5.858000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.269950E-01
Grade 1-vs-Grade 3
1.949590E-01
Grade 1-vs-Grade 4
1.425760E-01
Grade 2-vs-Grade 3
7.358600E-01
Grade 2-vs-Grade 4
9.863900E-02
Grade 3-vs-Grade 4
5.858000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.025900E-02
Normal-vs-NonDiabetic
2.035800E-01
Diabetic-vs-NonDiabetic
7.792300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.323000E-01
Normal-vs-NoPancreatitis
1.372620E-01
Pancreatitis-vs-NoPancreatitis
3.239200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.799400E-01
Normal-vs-N1
1.191010E-01
N0-vs-N1
6.393800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.972420E-01
Normal-vs-TP53-NonMutant
5.283400E-01
TP53-Mutant-vs-TP53-NonMutant
9.981800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
